{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:14:07Z","timestamp":1788880447013,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Chinese Academy of Sciences Youth Innovation Promotion Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103041","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:09:27Z","timestamp":1785251367000},"page":"103041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2"],"prefix":"10.1016","volume":"37","author":[{"given":"Xinlan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7691-334X","authenticated-orcid":false,"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingrui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6335-7769","authenticated-orcid":false,"given":"Pengfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-5138","authenticated-orcid":false,"given":"Xiaoyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103041_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s43856-024-00633-5","article-title":"Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza","volume":"4","author":"Bartha","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.omtn.2026.103041_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12931-024-02862-7","article-title":"Influenza A, influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era","volume":"25","author":"Lu\u0161trek","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.omtn.2026.103041_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41467-025-55938-3","article-title":"Evolution of omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology","volume":"16","author":"Wickenhagen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103041_bib5","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2026.103041_bib6","article-title":"SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early omicron subvariants but not BQ.1.1 or XBB.1.5","volume":"5","author":"Abbad","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtn.2026.103041_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp8920","article-title":"SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity","volume":"16","author":"Lasrado","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.103041_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103041_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55087-z","article-title":"Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: Preclinical and phase 1 clinical trials","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/22221751.2022.2056524","article-title":"A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates","volume":"11","author":"An","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.omtn.2026.103041_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep33987","article-title":"Epigraph: A vaccine design tool applied to an HIV therapeutic vaccine and a pan-filovirus vaccine","volume":"6","author":"Theiler","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103041_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.1742","article-title":"Efficient mucosal vaccination mediated by the neonatal fc receptor","volume":"29","author":"Ye","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103041_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41421-021-00320-y","article-title":"RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates","volume":"7","author":"Pan","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtn.2026.103041_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01279-23","article-title":"Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants","volume":"97","author":"Wu","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.103041_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114708","article-title":"Defining bottlenecks and opportunities for lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses","volume":"43","author":"Brouwer","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.103041_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-026-01375-2","article-title":"Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies","volume":"11","author":"Wu","year":"2026","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103041_bib17","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/s41467-023-42796-0","article-title":"An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105634","article-title":"SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion","volume":"114","author":"Ruan","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2026.103041_bib19","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.0801717105","article-title":"Dependence of antibody-mediated presentation of antigen on FcRn","volume":"105","author":"Qiao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103041_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-022-00612-2","article-title":"A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2026.103041_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00411-1","article-title":"The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2","volume":"5","author":"Du","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.omtn.2026.103041_bib22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.scib.2023.09.048","article-title":"Classification of five SARS-CoV-2 serotypes based on RBD antigenicities","volume":"68","author":"Hu","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.omtn.2026.103041_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.chom.2023.05.017","article-title":"Broad-spectrum pan-genus and pan-family virus vaccines","volume":"31","author":"Tan","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2026.103041_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00997-25","article-title":"Broad-spectrum vaccines against various and evolving viruses: From antigen design to nanoparticle delivery","volume":"99","author":"Cao","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.103041_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo3332","article-title":"Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice","volume":"15","author":"Zhao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.103041_bib26","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1016\/j.cell.2024.07.052","article-title":"Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals","volume":"187","author":"Cohen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103041_bib27","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41467-025-59182-7","article-title":"Epitope-optimized vaccine elicits enduring immunity against swine influenza a virus","volume":"16","author":"Petro-Turnquist","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41467-021-21508-6","article-title":"Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus","volume":"12","author":"Bullard","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41541-022-00492-y","article-title":"An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets","volume":"7","author":"Bullard","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103041_bib30","doi-asserted-by":"crossref","first-page":"20824","DOI":"10.1021\/acsnano.5c03199","article-title":"Epitope-optimized influenza hemagglutinin nanoparticle vaccine provides broad cross-reactive immunity against H9N2 influenza virus","volume":"19","author":"Hao","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.103041_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2026.103041_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/v12050520","article-title":"The effects of pre-existing antibodies on live-attenuated viral vaccines","volume":"12","author":"Mok","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2026.103041_bib33","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1080\/22221751.2021.1951126","article-title":"Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: A randomized, double-blind, placebo-controlled, phase I trial","volume":"10","author":"Zhang","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.omtn.2026.103041_bib34","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1038\/s41467-025-62800-z","article-title":"Immunogenicity and safety of a recombinant gE-fc fusion protein subunit vaccine for herpes zoster in adults \u226550 years of age: A randomised, active-controlled, non-inferiority trial","volume":"16","author":"Jin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib35","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/s41467-025-59353-6","article-title":"An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models","volume":"16","author":"Anthi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103041_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41541-025-01155-4","article-title":"An RBD-fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters","volume":"10","author":"Zhang","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103041_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.omtn.2026.103041_bib38","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.103041_bib39","doi-asserted-by":"crossref","first-page":"28038","DOI":"10.1074\/jbc.M202367200","article-title":"Functional reconstitution of human FcRn in madin-darby canine kidney cells requires co-expressed human \u03b22-microglobulin","volume":"277","author":"Claypool","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.103041_bib40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:03:45Z","timestamp":1788879825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S216225312600212X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103041","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103041"}}